Study on optimal dose of rocuronium administration during general anesthesia

Study on optimal dose of rocuronium administration during general anesthesia - Study on optimal dose of rocuronium administration during general anesthesia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010129

Enrollment

Registered

2013-02-26

Start date

2011-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult surgical patients undergoing general anesthesia

Interventions

Sevoflurane group Desflurane group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult surgical patients undergoing general anesthesia

Exclusion criteria

Exclusion criteria: 1.patients with liver and renal dysfunction 2.patients with neuromuscular disease

Design outcomes

Primary

Measure	Time frame
Predicted plasma and effectsite concentration (Cp, Ce) at 1st and 2nd recovery from neuromuscular block.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026